Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9543362rdf:typepubmed:Citationlld:pubmed
pubmed-article:9543362lifeskim:mentionsumls-concept:C0376574lld:lifeskim
pubmed-article:9543362lifeskim:mentionsumls-concept:C0042769lld:lifeskim
pubmed-article:9543362lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:9543362lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:9543362lifeskim:mentionsumls-concept:C0011945lld:lifeskim
pubmed-article:9543362pubmed:issue2lld:pubmed
pubmed-article:9543362pubmed:dateCreated1998-6-8lld:pubmed
pubmed-article:9543362pubmed:abstractTextThe aim of the present study was to use a combination of the reverse transcription-polymerase chain reaction and a new diagnostic test for antibodies against the viral envelope protein E2 to assess the prevalence of hepatitis G virus (GBV-C/HGV) infection in sera of Hungarian children on hemodialysis (HD) or peritoneal dialysis (CAPD), as well as in sera of renal transplant patients (RTx). The GBV-C/HGV RNA prevalence was significantly higher in the whole group of children with renal failure (18.5%) than in the control group (children with urinary tract infection, 2.5%). The difference between the GBV-C/HGV RNA prevalence in the RTx group (33.3%) and in the control group (2.5%) was significant (P = 0.007). Anti-E2, which is considered an indicator of a past GBV-C/ HGV infection, was detected in 10% (1/10) of HD patients, in 33.3% (4/12) of RTx patients, but in none of the children on CAPD. These differences were not significant. Children receiving a renal graft are at an increased risk of developing GBV-C/HGV infection, which may be attributed to the immunosuppressive drugs necessary to maintain the grafts.lld:pubmed
pubmed-article:9543362pubmed:languageenglld:pubmed
pubmed-article:9543362pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9543362pubmed:citationSubsetIMlld:pubmed
pubmed-article:9543362pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9543362pubmed:statusMEDLINElld:pubmed
pubmed-article:9543362pubmed:monthFeblld:pubmed
pubmed-article:9543362pubmed:issn0931-041Xlld:pubmed
pubmed-article:9543362pubmed:authorpubmed-author:PhilippTTlld:pubmed
pubmed-article:9543362pubmed:authorpubmed-author:SzaboAAlld:pubmed
pubmed-article:9543362pubmed:authorpubmed-author:RoseAAlld:pubmed
pubmed-article:9543362pubmed:authorpubmed-author:TulassayTTlld:pubmed
pubmed-article:9543362pubmed:authorpubmed-author:RoggendorfMMlld:pubmed
pubmed-article:9543362pubmed:authorpubmed-author:SallayPPlld:pubmed
pubmed-article:9543362pubmed:authorpubmed-author:KribbenAAlld:pubmed
pubmed-article:9543362pubmed:authorpubmed-author:HeemannUUlld:pubmed
pubmed-article:9543362pubmed:issnTypePrintlld:pubmed
pubmed-article:9543362pubmed:volume12lld:pubmed
pubmed-article:9543362pubmed:ownerNLMlld:pubmed
pubmed-article:9543362pubmed:authorsCompleteYlld:pubmed
pubmed-article:9543362pubmed:pagination93-5lld:pubmed
pubmed-article:9543362pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:meshHeadingpubmed-meshheading:9543362-...lld:pubmed
pubmed-article:9543362pubmed:year1998lld:pubmed
pubmed-article:9543362pubmed:articleTitleHepatitis G virus infection in children on dialysis and after renal transplantation.lld:pubmed
pubmed-article:9543362pubmed:affiliationDepartment of Nephrology, University Hospital Essen, Germany.lld:pubmed
pubmed-article:9543362pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9543362pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9543362lld:pubmed